Regulation of tissue-type plasminogen activator and plasminogen activator inhibitor type-1 in cultured rat Sertoli and Leydig cells

Sci China C Life Sci. 1996 Feb;39(1):37-44.

Abstract

New data are provided to show that (i) rat Sertoli cells produce two types of plasminogen activators, tissue type (tPA) and urokinase type (uPA), and a plasminogen activator inhibitor type-1 (PAI-1); (ii) both tPA (but not uPA) and PAI-1 secretion in the culture are modified by FSH, forskolin, dbcAMP, GnRH, PMA and growth factors (EGF and FGF), but not by hCG and androstenedione (delta 4); (iii) in vitro secretion of tPA and PA-PAI-1 complexes of Sertoli cells are greatly enhanced by presence of Leydig cells which produce negligible tPA but measurable PAI-1 activity; (iv) combination culture of Sertoli and Leydig cells remarkably increases FSH-induced PAI-1 activity and decreases hCG- and forskolin-induced inhibitor activity as compared with that of two cell types cultured alone. These data suggest that rat Sertoli cells, similar to ovarian granulosa cells, are capable of secreting both tPA and uPA, as well as PAI-1. The interaction of Sertoli cells and Leydig cells is essential for the cells to response to hormone stimulation for tPA and PAI-1 secretion.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cells, Cultured
  • Chorionic Gonadotropin / pharmacology
  • Colforsin / pharmacology
  • Follicle Stimulating Hormone / pharmacology
  • Leydig Cells / metabolism*
  • Leydig Cells / physiology
  • Male
  • Plasminogen Activator Inhibitor 1 / metabolism*
  • Rats
  • Rats, Sprague-Dawley
  • Sertoli Cells / metabolism*
  • Sertoli Cells / physiology
  • Tissue Plasminogen Activator / metabolism*

Substances

  • Chorionic Gonadotropin
  • Plasminogen Activator Inhibitor 1
  • Colforsin
  • Follicle Stimulating Hormone
  • Tissue Plasminogen Activator